Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed)
ID: 343407Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The National Institutes of Health (NIH) is offering Bioengineering Research Grants (BRG) under the funding opportunity announcement PAR-22-242, aimed at fostering interdisciplinary collaborations between life and physical sciences to address critical biomedical challenges. The grants encourage innovative research that enhances understanding of health and disease, improves medical practices, and meets unmet clinical needs, with applications being accepted from a diverse range of eligible entities, including educational institutions and community organizations. This funding opportunity is crucial for driving technological advancements in biomedical research, with a funding period of up to five years, contingent upon NIH appropriations, and applications must be submitted by September 7, 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    Files
    Title
    Posted
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is announcing the Bioengineering Research Grants (BRG) (R01 Clinical Trial Not Allowed) under FOA number PAR-22-242. This funding opportunity aims to foster interdisciplinary collaborations between life sciences and physical sciences to develop innovative bioengineering solutions to critical biomedical problems. Projects should propose research that enhances understanding of health and disease, improves medical practices, and fulfills unmet clinical needs. Applications can be new or involve resubmissions and must align with the missions of participating NIH institutes, including NCI, NEI, NIAMS, NICHD, NIDCR, NIDCD, and NINDS. Applicants are encouraged to submit distinct applications for different scientific inquiries. The application process requires adherence to strict guidelines and registration through NIH’s submission platforms. Key eligibility criteria include various educational and governmental entities, with a focus on diverse participation in research. The overall goal is to drive technological advancements in biomedical research with a funding period of up to five years, contingent upon NIH appropriations. Successful applications will undergo peer review for scientific merit and must demonstrate innovative approaches that advance knowledge in the biomedical fields. Applicants are urged to finalize submissions by outlined deadlines to ensure adherence to compliance expectations and avoid delays in funding.
    Similar Opportunities
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering funding through the Exploratory/Developmental Bioengineering Research Grants (EBRG) program, aimed at enhancing biomedical research and clinical care. This initiative encourages innovative applications that focus on developing new capabilities to address challenges in biomedical, preclinical, or clinical settings, with an emphasis on feasibility testing and novel methodologies. The program is particularly significant for advancing cancer research through innovative bioengineering approaches, welcoming proposals from a diverse range of eligible applicants, including universities, nonprofits, and small businesses, especially those representing underrepresented groups. The maximum budget for applicants is $275,000 over two years, with applications due by January 7, 2028. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-321.html.
    Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed), aimed at advancing innovative bioengineering solutions to address cancer and other biomedical challenges. This funding opportunity encourages projects that demonstrate the feasibility and potential utility of novel capabilities to enhance biomedical research, clinical care delivery, and accessibility, while specifically discouraging clinical trial proposals. Eligible applicants include a diverse range of institutions such as higher education entities, nonprofits, for-profit organizations, and foreign entities, with a funding cap of $275,000 available over a two-year period. Interested applicants can find more information and submission guidelines on the NIH website, with applications due by January 7, 2028. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Bioengineering Partnerships with Industry (U01 Clinical Trial Optional)" aimed at fostering collaborative research partnerships between academic and industrial investigators to accelerate the development of innovative bioengineering tools and technologies. The program seeks to establish multidisciplinary teams that apply a quantitative bioengineering approach to address significant biomedical challenges, with a focus on creating robust solutions that can enhance life science understanding and medical practices within a 5-10 year timeframe. Eligible applicants include a diverse range of organizations such as higher education institutions, nonprofits, and for-profit entities, particularly those emphasizing diversity in research. Interested parties should note that the application deadline is September 7, 2027, and for further inquiries, they can contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information page at https://grants.nih.gov/grants/guide/pa-files/PAR-24-325.html.
    National Centers for Biomedical Imaging and Bioengineering (NCBIB) (P41 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "National Centers for Biomedical Imaging and Bioengineering (NCBIB)" aimed at supporting the development and dissemination of new biomedical technologies. This initiative encourages applications from a diverse range of eligible entities, including higher education institutions and nonprofit organizations, to conduct technology research and development projects, collaborative projects, and service projects that address biomedical challenges. The program is designed to foster innovative research and enhance clinical applications, with funding typically ranging from $600,000 to $750,000 per project, and awards may last up to five years, with a total funding cap of fifteen years for any Center. Interested applicants should note that the application process opens on September 25, 2023, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov. For more details, please refer to the full announcement available at https://grants.nih.gov/grants/guide/pa-files/PAR-23-235.html.
    Bioengineering Research, Innovation and Technology Education (BRITE) Program (R25 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Bioengineering Research, Innovation and Technology Education (BRITE) Program, a federal grant aimed at fostering the development of undergraduate students in bioengineering and related STEM fields. This program encourages private institutions of higher education to propose integrated educational activities that include a summer bridge program for incoming freshmen, academic year activities, and summer research experiences, ultimately guiding participants toward doctoral degrees or research careers in bioengineering and biomedical imaging. The BRITE Program is crucial for enhancing the capacity for rigorous bioengineering training and addressing the nation's health-related research needs. Interested applicants can contact Dr. Tina Gatlin at gatlincl@nih.gov or by phone at 240-731-3794, with the estimated project start date set for March 1, 2027, and the application window closing on May 11, 2026.
    NIGMS Institutional Biomedical Undergraduate Research Training Program
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NIGMS Institutional Biomedical Undergraduate Research Training Program, a federal grant aimed at enhancing research training environments at institutions of higher education. This program seeks to develop a well-trained pool of undergraduate students who will transition into advanced biomedical research-focused degree programs, such as Ph.D. or M.D./Ph.D., by providing full-time support for 2-3 years of undergraduate biomedical research training. The initiative is particularly important for addressing the nation's biomedical, behavioral, and clinical research needs, especially at institutions with modest levels of NIH research project grant funding, including partnerships with community colleges. Interested applicants, specifically private institutions of higher education, can reach out to Behrous Davani, Ph.D., at behrous.davani@nih.gov or call 301-496-1058 for further information. The estimated synopsis close date is January 25, 2026, with an anticipated award date of October 1, 2026.
    NIGMS National and Regional Resources
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "NIGMS National and Regional Resources," aimed at supporting resources that enhance biomedical research capabilities for a large number of investigators. This program seeks to provide access to state-of-the-art technologies and expertise, enabling substantial numbers of researchers to benefit from resources that may not be available at individual institutions. The grant is open to small businesses, with no cost-sharing or matching requirements, and is categorized under discretionary funding with an estimated award date of June 1, 2026. Interested applicants can reach out to Han Nguyen, Ph.D., at han.nguyen@nih.gov or call 301-594-4640 for further information, and should note that the application period will close on September 25, 2025.
    Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Small Grants for New Investigators to Broaden Participation in Health-Related Research (R21 Clinical Trial Optional)." This initiative aims to support new investigators from diverse and underrepresented backgrounds in biomedical research, enabling them to conduct small-scale projects that align with the scientific mission areas of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) and other participating institutes. The grants, with a maximum budget of $125,000 per year for a project period not exceeding three years, are intended to facilitate the transition of these researchers toward independence while addressing health disparities. Interested applicants must demonstrate that they have had less than $125,000 in direct costs from combined active research funding and can submit proposals starting in early 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov, and additional details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-097.html.
    Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Collaborative Program Grant for Multidisciplinary Teams (RM1), aimed at funding integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to tackle complex biomedical questions. This initiative emphasizes the need for collaborative efforts that demonstrate synergy and diversity, with the goal of achieving significant scientific advancements within the mission of the National Institute of General Medical Sciences (NIGMS). Funding is available for new, renewal, and resubmission applications, with anticipated budgets ranging from $700,000 to $1.5 million per year, and applications must be submitted by January 27, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Bridges to the Doctorate Research Training Program (T32)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Bridges to the Doctorate Research Training Program (T32), a federal grant aimed at enhancing participation in the biomedical research workforce by improving training for master's students and facilitating their transition to Ph.D. programs. This program seeks to support eligible domestic organizations in developing effective, evidence-informed approaches to biomedical graduate training and mentoring, with a strong emphasis on outreach to underrepresented groups to promote diversity within the research community. The initiative requires partnerships between at least two postsecondary educational organizations—one focused on master's training and the other on Ph.D. training—while providing comprehensive financial support for trainees, including stipends and travel expenses. Interested applicants must adhere to strict eligibility criteria, with a preference for institutions such as Historically Black Colleges and Universities (HBCUs) and Tribally Controlled Colleges and Universities (TCCUs). The application deadline is September 28, 2026, and further inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.